In vivo Analysis of the Anti-atrial Fibrillatory, Proarrhythmic and Cardiodepressive Profiles of Dronedarone as a Guide for Safety Pharmacological Evaluation of Antiarrhythmic Drugs-Reference-Cited by-同舟云学术

In vivo Analysis of the Anti-atrial Fibrillatory, Proarrhythmic and Cardiodepressive Profiles of Dronedarone as a Guide for Safety Pharmacological Evaluation of Antiarrhythmic Drugs

Published:2017-11-14 Issue:3 Volume:18 Page:242-251
ISSN:1530-7905
Container-title:Cardiovascular Toxicology
language:en
Short-container-title:Cardiovasc Toxicol

Author:

Motokawa Yoshiyuki,Nakamura Yuji,Hagiwara-Nagasawa Mihoko,Goto Ai,Chiba Koki,Lubna Nur Jaharat,Izumi-Nakaseko Hiroko,Ando Kentaro,Naito Atsuhiko T.,Yamazaki Hiroshi,Sugiyama Atsushi

Funder

JSPS KAKENHI

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology

Link

http://link.springer.com/article/10.1007/s12012-017-9434-y/fulltext.html

Reference29 articles.

1. Patel, C., Yan, G. X., & Kowey, P. R. (2009). Dronedarone. Circulation., 120, 636–644.

2. Singh, B. N., Connolly, S. J., Crijns, H. J., Roy, D., Kowey, P. R., Capucci, A., et al. (2007). Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. New England Journal of Medicine, 357, 987–999.

3. Hohnloser, S. H., Crijns, H. J., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C., et al. (2009). Effect of dronedarone on cardiovascular events in atrial fibrillation [published correction appears in N Engl J Med. 2011;364:1481]. New England Journal of Medicine, 360, 668–678.